Sildenafil 10mg/mL; pwd for oral susp after reconstitution; grape flavor; contains sorbitol. Pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay ...
Nov. 7, 2005 — The European Commission has approved palifermin injection to reduce the incidence, duration, and severity of oral mucositis secondary to myeloablative therapy in patients with ...
Bologna, Italy - Sildenafil --perhaps best known as the active ingredient in the impotence therapy Viagra (Pfizer) -- is now also available for use in the treatment of pulmonary arterial hypertension ...
(Reuters) - U.S. health regulators recommended against use of Pfizer Inc's pulmonary arterial hypertension (PAH) drug Revatio in children up to 17 years of age, saying it had a higher risk of death ...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. announced that Revatio ® (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years old with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results